Tiefgehende Analysen für Pharma-Fachleute
Hintergründe zu Forschung, Innovation und Markttrends — der Kontext hinter den Schlagzeilen, geschrieben für Menschen aus der Branche.
MarktentwicklungenTop 10 Digital Transformation Leaders In The Pharma Industry In India
Meet the 10 visionary leaders driving digital transformation across India's pharmaceutical industry through AI, automation and smart manufacturing.
ForschungGPT-Rosalind, Explained: What OpenAI's First Life Sciences Model Actually Changes for Pharma R&D
GPT-Rosalind explained OpenAI's first life sciences model, its benchmarks, gated access, and implications for global pharma R&D teams.
ForschungHow Anti-CD8 Alpha Antibody Helps in Determining Failure of a Treatment
Discover how anti-CD8 Alpha antibody helps researchers track T-cell response in immunotherapy and cancer diagnostics.
ForschungComputer System Validator (CSV) vs. Computer System Assurance (CSA): What Are the Main Differences?
Guide to Computer System Validation (CSV) vs Computer Software Assurance (CSA) in pharma with key differences and risk-based approach.
InnovationPreclinical Screening Of Antihypertensive Agents: A Detailed Guide For Pharma Professionals
A detailed guide to preclinical screening of antihypertensive agents for pharma professionals.
Marktentwicklungen6 Cost Pressures Quietly Eroding Pharma Profit Margins & How Leaders Are Responding
Six hidden cost pressures squeezing pharma margins and how leaders are protecting profitability in 2026.
Marktentwicklungen7 Ways Rising Regulatory Pressure Is Reshaping Pharma Manufacturing Economics
How rising regulatory pressure is transforming cost structures and strategy in pharma manufacturing.
ForschungPROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug Discovery
How PROTACs and molecular glues are redefining drug discovery through targeted protein degradation strategies.
20260213135839.webp&w=1920&q=75&dpl=dpl_Fe2VLXz7WmA2eVjpEbUc2scjDNEB)
ForschungNeuroinflammation As A Target Class: The New Frontier In CNS Drug Development
Why neuroinflammation is emerging as a major target class reshaping CNS drug development and neurology research.
ForschungSenolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing
How senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.
20260212173840.webp&w=1920&q=75&dpl=dpl_Fe2VLXz7WmA2eVjpEbUc2scjDNEB)
ForschungPsychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of Medicines
How psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.
InnovationLive Biotherapeutic Products: The Future of Microbiome-Based Medicine
A deep dive into the clinical development, safety considerations, and commercial future of live biotherapeutic products.